Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

BACKGROUND: Combining different cancer treatments represents a promising strategy to improve the therapeutic outcome for lung cancer patients with or without druggable gene alterations. METHODS: We previously developed a polyethylene glycol-based (PEG-based) immunostimulatory nanocarrier (PEG(2k)-Fm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Diao, Dingwei, Zhai, Jianxue, Yang, Jianjun, Wu, Hua, Jiang, Jianjun, Dong, Xiaoying, Passaro, Antonio, Aramini, Beatrice, Rao, Shuan, Cai, Kaican
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947404/
https://ncbi.nlm.nih.gov/pubmed/33718033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-21-144
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars